Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/05/03/2434152/0/en/reMYND-s-novel-Alzheimer-program-reports-excellent-brain-exposure-and-safety-profile-in-Phase-1-transitioning-into-Phase-2a.html
https://www.globenewswire.com/news-release/2021/11/04/2327275/0/en/reMYND-and-the-US-NINDS-Epilepsy-Therapy-Screening-Program-ETSP-begin-collaboration-on-epilepsy-program.html
https://www.globenewswire.com/news-release/2021/10/21/2318160/0/en/reMYND-s-ReS19-T-program-managing-calcium-homeostasis-for-Alzheimer-s-has-moved-to-MAD-phase-after-demonstrating-strong-safety-in-SAD-phase.html